Similar companies
Income Statement (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 17.3B | 9.3% |
| Gross Profit | 13.4B | 9.6% |
| Cost of Revenue | 3.86B | 8.4% |
| Operating expense | 6.87B | 2.5% |
| Net Income | 5.79B | 30.7% |
| EBITDA | 8.23B | 28.1% |
Balance Sheet (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 130B | 10.2% |
| Total Liabilities | 77.6B | 13.4% |
| Total Equity | 51.9B | 5.8% |
| Shares Outstanding | 2.5B | 0.6% |
Cash Flow (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 7.82B | 137.5% |
| Cash from investing | -283M | 63.2% |
| Cash from financing | 2.64B | 174.2% |
EPS
Financial Highlights for Merck & Company in Q3 '25
Merck & Company reported a revenue of 17.3B, which is a 9.3% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 13.4B, marking a 9.6% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 3.86B, a 8.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 6.87B, showing a 2.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 5.79B, showing a 30.7% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 8.23B, showing a 28.1% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Merck & Company with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
